# US 2025/0075195 A1 · Esterase Mutant and Use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0075195 A1
- Document ID: US20250075195A1
- Status: Published application
- Kind: A1
- Application number: 18/293,146
- Filed: 2021-09-18
- Published: 2025-03-06
- Earliest claimed: 2021-07-28
- Assignees: Asymchem Laboratories (Tianjin) Co., Ltd.
- Applicants: Asymchem Laboratories (Tianjin) Co., Ltd.
- Inventors: Hao Hong; James Gage; Yi Xiao; Na Zhang; Xuecheng Jiao; Yiming Yang; Juan Li; Qixing Huang
- Web page: https://patentgrep.com/patent/US20250075195A1

## CPC

- C12N 9/18: Carboxylic ester hydrolases {(3.1.1)}
- C12Y 301/01017: Gluconolactonase (3.1.1.17)
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/81: for yeasts
- C12P 7/02: containing a hydroxy group
- C12P 7/40: containing a carboxyl group {including Peroxycarboxylic acids}
- C12Y 301/01078: Polyneuridine-aldehyde esterase (3.1.1.78)
- C12Y 301/0108: Acetylajmaline esterase (3.1.1.80)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Provided are an esterase mutant and the use thereof. The esterase mutant obtained by means of rational design and several rounds of evolution screening with enzymes on the basis of an amino acid sequence as shown in SEQ ID NO: 1 is changed in terms of protein structure and function compared with a wild-type esterase; in practical use, the catalytic activity and/or stereoselectivity of the esterase mutant is greatly improved; and when a system contains some organic cosolvents, the esterase mutant still has relatively stable catalytic activity and/or stereoselectivity. In addition, the improvement of the catalytic activity and/or stereoselectivity of the esterase mutant reduces the use amount of the enzyme to a certain extent and reduces the difficulty of post-treatment, and therefore the esterase mutant is suitable for industrial production.

## Claims

### Claim 1

An esterase mutant, wherein the esterase mutant comprises:
(a) a protein having the amino acid sequence of SEQ ID NO: 1 with a mutation of one or more amino acids and having a esterase activity, wherein the mutation comprises any one or more of the group consisting of: G19S, G19S+H86S, G19S+H86A, G19S+H86Q, G19S+H86M, G19S+H86T, G19S+H86C, G19S+H86N, G19S+F88N, G19S+F88R, G19S+F88Y, G19S+F88K, G19S+S111T, G19S+S111V, G19S+M113I, G19S+M113L, G19S+M113V, G19S+F125Y, G19S+F125S, G19S+Y128F, G19S+L157V, G19S+M166L, G19S+L187V, G19S+L187I, G19S+S218Y, G19S+S218H, G19S+S218F, G19S+S218N, G19S+H86S+S111T, G19S+H86S+S111V, G19S+H86S+M113A, G19S+H86S+M113G, G19S+H86S+M113I, G19S+H86S+M113L, G19S+H86S+M113V, G19S+H86S+M113I+L157A, G19S+H86S+M113I+L157G, G19S+H86S+M113I+L157V, G19S+H86A+S111T, G19S+H86A+S111V, G19S+H86A+M113A, G19S+H86A+M113G, G19S+H86A+M113I, G19S+H86A+M113L, G19S+H86A+M113V, G19S+H86A+M113I+S218E, G19S+H86A+M113I+S218F, G19S+H86A+M113I+S218I, G19S+H86A+M113I+S218L, G19S+H86A+M113I+S218M, G19S+H86A+M113I+S218T, G19S+H86A+M113I+S218V, G19S+H86A+M113I+S218Y, G19S+H86A+M113I+S218F+A86C, G19S+H86A+M113I+S218F+A86M, G19S+H86A+M113I+S218F+A86N, G19S+H86A+M113I+S218F+A86Q, G19S+H86A+M113I+S218F+A86S, G19S+H86A+M113I+S218F+M137F, G19S+H86A+M113I+S218F+M137L, G19S+H86A+M113I+S218F+M137Y, G19S+H86A+M113I+S218F+M137E, G19S+H86A+M113I+S218F+M137W, G19S+H86A+M113I+S218F+F219Y, G19S+H86A+M113I+S218F+F219L, G19S+H86A+M113I+S218F+F219T, G19S+H86A+M113I+S218F+F219Q, G19S+H86A+M113I+S218F+F219Y+M137F, G19S+H86A+M113I+S218F+F219Y+M137L, G19S+H86A+M113I+S218F+F219Y+M137W, G19S+H86A+M113I+S218F+F219Y+M137Y or G19S+H86A+M113I+S218F+F219Y+M137S; or
(b) a protein with an amino acid sequence having 80% or higher identity to the protein of (a).

### Claim 2 (depends on 1)

The esterase mutant according to claim 1, wherein the esterase mutant has an amino acid sequence having 90% or higher, preferably 95% or higher, and more preferably 99% or higher identity to the protein of (a).

### Claim 3 (depends on 1)

The esterase mutant according to claim 1, wherein the esterase mutant is derived from Rauvolfia serpentina.

### Claim 4 (depends on 1)

A DNA molecule, coding the esterase mutant according to claim 1.

### Claim 5 (depends on 4)

A recombinant plasmid, connected with the DNA molecule according to claim 4.

### Claim 6 (depends on 5)

The recombinant plasmid according to claim 5, wherein the recombinant plasmid is selected from any one of the group consisting of: pET-21b(+), pET-22b(+), pET-3a(+), pET-3d(+), pET-11a(+), pET-12a(+), pET-14b, pET-15b(+), pET-16b(+), pET-17b(+), pET-19b(+), pET-20b(+), pET-21a(+), pET-23a(+), pET-23b(+), pET-24a(+), pET-25b(+), pET-26b(+), pET-27b(+), pET-28a(+), pET-29a(+), pET-30a(+), pET-31b(+), pET-32a(+), pET-35b(+), pET-38b(+), pET-39b(+), pET-40b(+), pET-41a(+), pET-41b(+), pET-42a(+), pET-43a(+), pET-43b(+), pET-44a(+), pET-49b(+), pQE2, pQE9, pQE30, pQE31, pQE32, pQE40, pQE70, pQE80, pRSET-A, pRSET-B, pRSET-C, pGEX-5X-1, pGEX-6p-1, pGEX-6p-2, pBV220, pBV221, pBV222, pTrc99A, pTwin1, pEZZ18, pKK232-8, pUC-18 and pUC-19.

### Claim 7 (depends on 5)

A non-plant host cell, comprising the recombinant plasmid according to claim 5.

### Claim 8 (depends on 7)

The host cell according to claim 7, wherein the host cell is a prokaryotic cell or an eukaryotic cell, and the eukaryotic cell is a yeast cell.

### Claim 9 (depends on 8)

The host cell according to claim 8, wherein the host cell is a competent cell.

### Claim 10 (depends on 9)

The host cell according to claim 9, wherein the competent cell is an Escherichia coli BL21 cell or an Escherichia coli W3110.

### Claim 11 (depends on 1)

A method for preparing a chiral compound, comprising:
catalyzing an ester compound as shown in Formula I with the esterase mutant according to claim 1 to be hydrolyzed into an acid compound as shown in Formula II and an alcohol compound as shown in Formula III,
wherein n=1, 2, 3 or 4;
X=C, O or S;
R1=CH3, CH2CH3, CH2—CH2CH3 or CHCH3CH3; and
R2=H, F, Cl, Br, CH3 or CH2CH3.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the ester compound is selected any one of the group consisting of:

### Claim 13 (depends on 11)

The method according to claim 11, wherein the esterase mutant catalyzes the ester compound as shown in Formula I to be hydrolyzed at a temperature of 20° C. to 40° C.

### Claim 14 (depends on 11)

The method according to claim 11, wherein the ester compound and the esterase are dissolved in a potassium phosphate buffer solution to form a catalytic reaction system, wherein the potassium phosphate buffer solution has a concentration of 0.1M to 1 M, and a pH value of 6.0 to 7.5.

### Claim 15 (depends on 11)

The method according to claim 11, wherein a mass ratio of the esterase mutant to the ester compound is 0.2 mg-2 mg: 20 mg.

### Claim 16 (depends on 11)

The method according to claim 11, wherein a mass ratio of the esterase mutant to the ester compound is 0.1 mg-0.5 g: 10 g.

### Claim 17 (depends on 14)

The method according to claim 14, wherein the catalytic reaction system further comprises a cosolvent, and the cosolvent is selected from any one of the group consisting of DMSO, DCM and 2-MeTHF.

### Claim 18 (depends on 17)

The method according to claim 17, wherein a volume percentage of the cosolvent in the reaction system is at most 20%.
